Glucocorticoid Receptor as a Potential Target to Decrease Aromatase Expression and Inhibit Leydig Tumor Growth

American Journal of Pathology

Volumn 186, Issue 5, 2016, Pages 1328-1339

  Panza, Salvatore ^a   Malivindi, Rocco ^a   Chemi, Francesca ^a   Rago, Vittoria ^a   Giordano, Cinzia ^a   Barone, Ines ^a   Bonofiglio, Daniela ^a   Gelsomino, Luca ^a   Giordano, Francesca ^a   Andò, Sebastiano ^a   Catalano, Stefania ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; KI 67 ANTIGEN; NUCLEAR RECEPTOR COREPRESSOR; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; AROMATASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; IN VIVO STUDY; LEYDIG CELL TUMOR; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; TUMOR REGRESSION; TUMOR XENOGRAFT; ANIMAL; ANTAGONISTS AND INHIBITORS; CANCER TRANSPLANTATION; DRUG EFFECTS; METABOLISM; NUDE MOUSE; PATHOLOGY; TESTICULAR NEOPLASMS; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; AROMATASE; AROMATASE INHIBITORS; CELL LINE, TUMOR; CELL PROLIFERATION; DEXAMETHASONE; HETEROGRAFTS; LEYDIG CELL TUMOR; MALE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RECEPTORS, GLUCOCORTICOID; TESTICULAR NEOPLASMS;

EID: 84963997628     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2015.12.024     Document Type: Article

References (56)

1. C. Hawkins, and C. Miaskowski Testicular cancer: a review Oncol Nurs Forum 23 1996 1203 1211
2. K.A. Fowler, K. Gill, N. Kirma, D.L. Dillehay, and R.R. Tekmal Overexpression of aromatase leads to development of testicular leydig cell tumors: an in vivo model for hormone-mediated Testicular Cancer Am J Pathol 156 2000 347 353
3. X. Li, L. Strauss, A. Kaatrasalo, A. Mayerhofer, I. Huhtaniemi, R. Santti, S. Mäkelä, and M. Poutanen Transgenic mice expressing p450 aromatase as a model for male infertility associated with chronic inflammation in the testis Endocrinology 147 2006 1271 1277
4. R. Sirianni, A. Chimento, R. Malivindi, I. Mazzitelli, S. Andò, and V. Pezzi Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor Leydig cell proliferation Cancer Res 67 2007 8368 8377
5. A. Carpino, V. Rago, V. Pezzi, C. Carani, and S. Andò Detection of aromatase and estrogen receptors (ERalpha, ERbeta1, ERbeta2) in human Leydig cell tumor Eur J Endocrinol 157 2007 239 244
6. A. Brodie, S. Inkster, and W. Yue Aromatase expression in the human male Mol Cell Endocrinol 178 2001 23 28
7. S.E. Bulun, I.M. Rosenthal, A.M. Brodie, S.E. Inkster, W.P. Zeller, A.M. DiGeorge, S.D. Frasier, M.W. Kilgore, and E.R. Simpson Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads J Clin Endocrinol Metab 78 1994 1616 1621
8. A.H. Straume, K. Løvås, H. Miletic, K. Gravdal, P.E. Lønning, and S. Knappskog Elevated levels of the steroidogenic factor 1 are associated with over-expression of CYP19 in an oestrogen-producing testicular Leydig cell tumour Eur J Endocrinol 166 2012 941 949
9. S. Catalano, R. Malivindi, C. Giordano, G. Gu, S. Panza, D. Bonofiglio, M. Lanzino, D. Sisci, M.L. Panno, and S. Andò Farnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase expression in tumor Leydig cells J Biol Chem 285 2010 5581 5593
10. S. Catalano, S. Panza, R. Malivindi, C. Giordano, I. Barone, G. Bossi, M. Lanzino, R. Sirianni, L. Mauro, D. Sisci, D. Bonofiglio, and S. Andò Inhibition of Leydig tumor growth by farnesoid X receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy Int J Cancer 132 2013 2237 2247
11. P. Maris, A. Campana, I. Barone, C. Giordano, C. Morelli, R. Malivindi, D. Sisci, S. Aquila, V. Rago, D. Bonofiglio, S. Catalano, M. Lanzino, and S. Andò Androgens inhibit aromatase expression through DAX-1: insights into the molecular link between hormone balance and Leydig cancer development Endocrinology 156 2015 1251 1262
12. S.A. Ortlip, S.A. Li, and J.J. Li Characterization of specific glucocorticoid receptor in the Syrian hamster testis Endocrinology 109 1981 1331 1338
13. A. Stalker, L. Hermo, and T. Antakly Covalent affinity labeling, radioautography, and immunocytochemistry localize the glucocorticoid receptor in rat testicular Leydig cells Am J Anat 186 1989 369 377
14. R. Schultz, J. Isola, M. Parvinen, J. Honkaniemi, A.C. Wikström, J.A. Gustafsson, and M. Pelto-Huikko Localization of the glucocorticoid receptor in testis and accessory sexual organs of male rat Mol Cell Endocrinol 95 1993 115 120
15. A. Bartke Effects of growth hormone on male reproductive functions J Androl 21 2000 181 188
16. M.P. Hardy, H.B. Gao, Q. Dong, R. Ge, Q. Wang, W.R. Chai, X. Feng, and C. Sottas Stress hormone and male reproductive function Cell Tissue Res 322 2005 147 153
17. H.B. Gao, L.X. Shan, C. Monder, and M.P. Hardy Suppression of endogenous corticosterone levels in vivo increases the steroidogenic capacity of purified rat Leydig cells in vitro Endocrinology 137 1996 1714 1718
18. H. Schwarzenbach, P.R. Manna, D.M. Stocco, G. Chakrabarti, and A.K. Mukhopadhyay Stimulatory effect of progesterone on the expression of steroidogenic acute regulatory protein in MA-10 Leydig cells Biol Reprod 68 2003 1054 1063
19. L.J. Martin, and J.J. Tremblay Glucocorticoids antagonize cAMP-induced Star transcription in Leydig cells through the orphan nuclear receptor NR4A1 J Mol Endocrinol 41 2008 165 175
20. D.B. Hales, and A.H. Payne Glucocorticoid-mediated repression of P450scc mRNA and de novo synthesis in cultured Leydig cells Endocrinology 124 1989 2099 2104
21. A.H. Payne, and L.L. Sha Multiple mechanisms for regulation of 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase, 17 alpha hydroxylase/C17-20 lyase cytochrome P450, and cholesterol side-chain cleavage cytochrome P450 messenger ribonucleic acid levels in primary cultures of mouse Leydig cells Endocrinology 129 1991 1429 1435
22. R. Badrinarayanan, S. Rengarajan, P. Nithya, and K. Balasubramanian Corticosterone impairs the mRNA expression and activity of 3beta- and 17beta-hydroxysteroid dehydrogenases in adult rat Leydig cells Biochem Cell Biol 84 2006 745 754
23. Y.C. Xiao, Y.D. Huang, D.O. Hardy, X.K. Li, and R.S. Ge Glucocorticoid suppresses steroidogenesis in rat progenitor Leydig cells J Androl 31 2010 365 371
24. N.H. Ing, D.W. Forrest, P.K. Riggs, S. Loux, C.C. Love, S.P. Brinsko, D.D. Varner, and T.H. Welsh Jr. Dexamethasone acutely down-regulates genes involved in steroidogenesis in stallion testes J Steroid Biochem Mol Biol 143 2014 451 459
25. H.B. Gao, M.H. Tong, Y.Q. Hu, Q.S. Guo, R. Ge, and M.P. Hardy Glucocorticoid induces apoptosis in rat leydig cells Endocrinology 143 2002 130 138
26. S. Catalano, I. Barone, C. Giordano, P. Rizza, H. Qi, G. Gu, R. Malivindi, D. Bonofiglio, and S. Andò Rapid estradiol/ERalpha signaling enhances aromatase enzymatic activity in breast cancer cells Mol Endocrinol 23 2009 1634 1645
27. M. Young, and M.J. McPhaul A steroidogenic factor-1-binding site and cyclic adenosine 3',5'-monophosphate response element-like elements are required for the activity of the rat aromatase promoter in rat Leydig tumor cell lines Endocrinology 139 1998 5082 5093
28. I. Barone, Y. Cui, M.H. Herynk, A. Corona-Rodriguez, C. Giordano, J. Selever, A. Beyer, S. Andò, and S.A. Fuqua Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway Cancer Res 69 2009 4724 4732
29. C. Giordano, Y. Cui, I. Barone, S. Ando, M.A. Mancini, V. Berno, and S.A. Fuqua Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor alpha and its phosphorylation at serine 305 Breast Cancer Res Treat 119 2010 71 85
30. S. Catalano, A. Leggio, I. Barone, R. De Marco, L. Gelsomino, A. Campana, R. Malivindi, S. Panza, C. Giordano, A. Liguaori, D. Bonofiglio, A. Liguori, and S. Andò A novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo J Cell Mol Med 19 2015 1122 1132
31. S. Catalano, V. Pezzi, A. Chimento, C. Giordano, A. Carpino, M. Young, M.J. McPhaul, and S. Andò Triiodothyronine decreases the activity of the proximal promoter (PII) of the aromatase gene in the mouse Sertoli cell line, TM4 Mol Endocrinol 17 2003 923 934
32. S. Aquila, D. Sisci, M. Gentile, A. Carpino, E. Middea, S. Catalano, V. Rago, and S. Andò Towards a physiological role for cytochrome P450 aromatase in ejaculated human sperm Hum Reprod 18 2003 1650 1659
33. S. Inkster, W. Yue, and A. Brodie Human testicular aromatase: immunocytochemical and biochemical studies J Clin Endocrinol Metab 80 1995 1941 1947
34. M. Young, E.D. Lephart, and M.J. McPhaul Expression of aromatase cytochrome P450 in rat H540 Leydig tumor cells J Steroid Biochem Mol Biol 63 1997 37 44
35. M. Lanzino, S. Catalano, C. Genissel, S. Ando, S. Carreau, K. Hamra, and M.J. McPhaul Aromatase messenger RNA is derived from the proximal promoter of the aromatase gene in Leydig, Sertoli, and germ cells of the rat testis Biol Reprod 64 2001 1439 1443
36. K. Ronacher, K. Hadley, C. Avenant, E. Stubsrud, S.S. Simons Jr., A. Louw, and J.P. Hapgood Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction Mol Cell Endocrinol 299 2009 219 231
37. H.U. Ahmed, M. Arya, A. Muneer, I. Mushtaq, and N.J. Sebire Testicular and paratesticular tumours in the prepubertal population Lancet Oncol 11 2010 476 483
38. W.G. McCluggage, J.H. Shanks, K. Arthur, and S.S. Banerjee Cellular proliferation and nuclear ploidy assessments augment established prognostic factors in predicting malignancy in testicular Leydig cell tumours Histopathology 33 1998 361 368
39. I. Woolveridge, M.F. Taylor, F.F. Rommerts, and I.D. Morris Apoptosis related gene products in differentiated and tumorigenic rat Leydig cells and following regression induced by the cytotoxin ethane dimethanesulphonate Int J Androl 24 2001 56 64
40. P.C. Azer, and G.D. Braunstein Malignant Leydig cell tumor: objective tumor response to o,p'-DDD Cancer 47 1981 1251 1255
41. S. Vandevyver, L. Dejager, and C. Libert Comprehensive overview of the structure and regulation of the glucocorticoid receptor Endocr Rev 35 2014 671 693
42. E.S. Alnemri, T.F. Fernandes, S. Haldar, C.M. Croce, and G. Litwack Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias Cancer Res 52 1992 491 495
43. E.B. Thompson, R. Thulasi, M.F. Saeed, and B.H. Johnson Glucocorticoid antagonist RU 486 reverses agonist-induced apoptosis and c-myc repression in human leukemic CEM-C7 cells Ann N Y Acad Sci 761 1995 261 275
44. P. Buse, P.L. Woo, D.B. Alexander, H.H. Cha, A. Reza, N.D. Sirota, and G.L. Firestone Transforming growth factor-alpha abrogates glucocorticoid-stimulated tight junction formation and growth suppression in rat mammary epithelial tumor cells J Biol Chem 270 1995 6505 6514
45. L. Goya, A.C. Maiyar, Y. Ge, and G.L. Firestone Glucocorticoids induce a G1/G0 cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-alpha Mol Endocrinol 7 1993 1121 1132
46. G.H. Frost, K. Rhee, T. Ma, and E.A. Thompson Expression of c-Myc in glucocorticoid-treated fibroblastic cells J Steroid Biochem Mol Biol 50 1994 109 119
47. I. Sánchez, L. Goya, A.K. Vallerga, and G.L. Firestone Glucocorticoids reversibly arrest rat hepatoma cell growth by inducing an early G1 block in cell cycle progression Cell Growth Differ 4 1993 215 225
48. S. Takayama, I. Rogatsky, L.E. Schwarcz, and B.D. Darimont The glucocorticoid receptor represses cyclin D1 by targeting the Tcf-β-catenin complex J Biol Chem 281 2006 17856 17863
49. D. Chebotaev, A. Yemelyanov, and I. Budunova The mechanisms of tumor suppressor effect of glucocorticoid receptor in skin Mol Carcinog 46 2007 732 740
50. A. Yemelyanov, J. Czwornog, D. Chebotaev, A. Karseladze, E. Kulevitch, X. Yang, and I. Budunova Tumor suppressor activity of glucocorticoid receptor in the prostate Oncogene 26 2007 1885 1896
51. P.S. Gaynon, and R.H. Lustig The use of glucocorticoids in acute lymphoblastic leukemia of childhood. Molecular, cellular, and clinical considerations J Pediatr Hematol Oncol 17 1995 1 12
52. B. Pirotte, M. Levivier, S. Goldman, J.M. Brucher, J. Brotchi, and J. Hildebrand Glucocorticoid-induced long-term remission in primary cerebral lymphoma: case report and review of the literature J Neurooncol 32 1997 63 69
53. S. Karmakar, Y. Jin, and A.K. Nagaich Interaction of glucocorticoid receptor (GR) with estrogen receptor (ER) α and activator protein 1 (AP1) in dexamethasone-mediated interference of ERα activity J Biol Chem 288 2013 24020 24034
54. R. Kumar, and E.B. Thompson Gene regulation by the glucocorticoid receptor: structure:function relationship J Steroid Biochem Mol Biol 94 2005 383 394
55. S. Ghisletti, W. Huang, K. Jepsen, C. Benner, G. Hardiman, M.G. Rosenfeld, and C.K. Glass Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways Genes Dev 23 2009 681 693
56. Q. Wang, J.A. Blackford Jr., L.N. Song, Y. Huang, S. Cho, and S.S. Simons Jr. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors Mol Endocrinol 18 2004 1376 1395